Robert L. Thomas

2.2k total citations
31 papers, 1.4k citations indexed

About

Robert L. Thomas is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Robert L. Thomas has authored 31 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Surgery. Recurrent topics in Robert L. Thomas's work include Mitochondrial Function and Pathology (7 papers), Autophagy in Disease and Therapy (5 papers) and Diet and metabolism studies (3 papers). Robert L. Thomas is often cited by papers focused on Mitochondrial Function and Pathology (7 papers), Autophagy in Disease and Therapy (5 papers) and Diet and metabolism studies (3 papers). Robert L. Thomas collaborates with scholars based in United States, China and Belgium. Robert L. Thomas's co-authors include Åsa B. Gustafsson, John R. Sedor, Melissa N. Quinsay, Youngil Lee, Dieter A. Kubli, Anne N. Murphy, Shivaji Rikka, Xie Zhang, Sunny Smith and Mark A. Sussman and has published in prestigious journals such as JAMA, Nature Communications and Genes & Development.

In The Last Decade

Robert L. Thomas

27 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert L. Thomas United States 11 603 446 200 158 115 31 1.4k
Xinghui Li China 17 233 0.4× 248 0.6× 196 1.0× 92 0.6× 42 0.4× 43 968
Danuta Zwołińska Poland 20 363 0.6× 128 0.3× 504 2.5× 159 1.0× 48 0.4× 147 1.6k
Krzysztof Laudański United States 18 386 0.6× 304 0.7× 73 0.4× 83 0.5× 97 0.8× 102 1.4k
Ayo P. Doumatey United States 27 646 1.1× 366 0.8× 253 1.3× 290 1.8× 22 0.2× 64 2.0k
Sylvain Mathieu France 26 295 0.5× 198 0.4× 55 0.3× 168 1.1× 81 0.7× 92 2.4k
Zhi Yu United States 22 219 0.4× 134 0.3× 123 0.6× 173 1.1× 112 1.0× 67 1.4k
Luigi Mario Castello Italy 23 413 0.7× 336 0.8× 89 0.4× 246 1.6× 25 0.2× 105 1.9k
Zhonglin Chai Australia 20 365 0.6× 195 0.4× 177 0.9× 127 0.8× 43 0.4× 52 1.6k
Bamidele O. Tayo United States 24 219 0.4× 169 0.4× 99 0.5× 151 1.0× 113 1.0× 92 1.6k

Countries citing papers authored by Robert L. Thomas

Since Specialization
Citations

This map shows the geographic impact of Robert L. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Thomas more than expected).

Fields of papers citing papers by Robert L. Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Thomas. The network helps show where Robert L. Thomas may publish in the future.

Co-authorship network of co-authors of Robert L. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Robert L. Thomas. A scholar is included among the top collaborators of Robert L. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert L. Thomas. Robert L. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giovannetti, Erin R., Robert L. Thomas, Rabia Ali, et al.. (2025). Continuous Glucose Monitoring–Guided Insulin Infusion in Critically Ill Patients Promotes Safety, Improves Time Efficiency, and Enhances Provider Satisfaction. Endocrine Practice. 31(9). 1143–1149.
2.
Thomas, Robert L., et al.. (2024). Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes. Diabetes Care. 47(5). e39–e41. 6 indexed citations
3.
Li, Jinghong, Qi Wei, Karen C. McCowen, et al.. (2021). Inpatient use of metformin and acarbose is associated with reduced mortality of COVID‐19 patients with type 2 diabetes mellitus. Endocrinology Diabetes & Metabolism. 5(1). e00301–e00301. 21 indexed citations
4.
Spence, Dingle, et al.. (2021). Implementing Palliative Care Training in the Caribbean: Development and Assessment of a Basic Palliative Care Training Course in Jamaica. Journal of Pain and Symptom Management. 62(6). 1145–1153. 4 indexed citations
5.
Li, Jinghong, Qi Wei, Willis X. Li, et al.. (2020). Metformin Use in Diabetes Prior to Hospitalization: Effects on Mortality in Covid-19. Endocrine Practice. 26(10). 1166–1172. 29 indexed citations
6.
Thomas, Robert L., Lingjing Jiang, John S. Adams, et al.. (2020). Vitamin D metabolites and the gut microbiome in older men. Nature Communications. 11(1). 5997–5997. 108 indexed citations
7.
Thomas, Robert L., David J. Roberts, Dieter A. Kubli, et al.. (2013). Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure. Genes & Development. 27(12). 1365–1377. 208 indexed citations
8.
Gunzler, Douglas, Anthony J. Bleyer, Robert L. Thomas, et al.. (2013). Diabetic nephropathy in a sibling and albuminuria predict early GFR decline: a prospective cohort study. BMC Nephrology. 14(1). 124–124. 6 indexed citations
9.
Thomas, Robert L. & Åsa B. Gustafsson. (2013). Mitochondrial Autophagy. Circulation Journal. 77(10). 2449–2454. 44 indexed citations
10.
Prakash, Sindhuri, Natalia Papeta, Roel Sterken, et al.. (2011). Identification of the Nephropathy-Susceptibility Locus HIVAN4. Journal of the American Society of Nephrology. 22(8). 1497–1504. 9 indexed citations
11.
Thomas, Robert L., Dieter A. Kubli, & Åsa B. Gustafsson. (2011). Bnip3-mediated defects in oxidative phosphorylation promote mitophagy. Autophagy. 7(7). 775–777. 35 indexed citations
12.
Quinsay, Melissa N., Robert L. Thomas, Youngil Lee, & Åsa B. Gustafsson. (2010). Bnip3-mediated mitochondrial autophagy is independent of the mitochondrial permeability transition pore. Autophagy. 6(7). 855–862. 200 indexed citations
13.
Rikka, Shivaji, Melissa N. Quinsay, Robert L. Thomas, et al.. (2010). Bnip3 impairs mitochondrial bioenergetics and stimulates mitochondrial turnover. Cell Death and Differentiation. 18(4). 721–731. 200 indexed citations
14.
Thomas, Robert L., et al.. (2008). Chronic Kidney Disease and Its Complications. Primary Care Clinics in Office Practice. 35(2). 329–344. 368 indexed citations
15.
Richardson, Janet, Karen Pilkington, & Robert L. Thomas. (2005). Complementary and alternative medicine evidence online for cancer. WestminsterResearch (University of Westminster). 3 indexed citations
16.
Sterling, David A., Bruce W. Clements, Terri Rebmann, et al.. (2005). Occupational physician perceptions of bioterrorism. International Journal of Hygiene and Environmental Health. 208(1-2). 127–134. 9 indexed citations
17.
Thomas, Robert L.. (1996). Management of Hip Fracture in the Geriatric Patient. Topics in Geriatric Rehabilitation. 12(1). 59–69. 3 indexed citations
18.
Denson, Donald D., et al.. (1988). Rapid Estimation of Unbound Lidocaine Clearance in Cardiac Patients: Implications for Reducing Toxicity. The Journal of Clinical Pharmacology. 28(11). 995–1000. 1 indexed citations
19.
Thomas, Robert L., et al.. (1987). Review of Intermittent Dobutamine Infusions for Congestive Cardiomyopathy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 7(2). 47–53. 5 indexed citations
20.
Edmonds, Carl & Robert L. Thomas. (1972). Medical aspects of diving. 2.. PubMed. 2(22). 1256–60. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026